RT Book, Section A1 Gottschalk, Alexander R. A1 Speight, Joycelyn L. A1 Roach, Mack A2 McAninch, Jack W. A2 Lue, Tom F. SR Print(0) ID 56946905 T1 Chapter 26. Radiotherapy of Urologic Tumors T2 Smith & Tanagho's General Urology, 18e YR 2013 FD 2013 PB The McGraw-Hill Companies PP New York, NY SN 978-0-07-162497-8 LK accesssurgery.mhmedical.com/content.aspx?aid=56946905 RD 2024/03/28 AB The primary management of genitourologic malignant diseases has been tied to the use of radiation for more than 100 years. In 1895, Roentgen described x-rays; by 1899, a patient with skin cancer was cured with radiation; and within 10 years, radiation was used to treat prostate cancer (Pasteau and Degrais, 1914). Radiotherapy became a mainstay of treatment for bladder and testicular cancers and later prostate cancer as supervoltage sources became available. Although chemotherapy and aggressive surgery have supplanted some of the uses of radiotherapy, radiation continues to play a major role in the management of carcinomas of the penis, urethra, prostate, and bladder. In this chapter, we review general principles and the indications for using radiation as a component in the primary management of urologic malignant diseases. The role of radiation as an agent of palliation has been well documented elsewhere and is excluded from this chapter.